Kristen Hall, APRN
Nurse Practitioner · Anderson, SCNPI 1346449550
Payments from drug & device makers
Across 250 payments — averaging $22.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$955
- GSK$752
- Regeneron Healthcare Solutions, Inc.$743
- Takeda Pharmaceuticals U.S.A., Inc.$448
- Sanofi$362
- Boehringer Ingelheim$334
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,63998%
- Education$962%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $955 |
| GSK | 43 | $752 |
| Regeneron Healthcare Solutions, Inc. | 15 | $743 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $448 |
| Sanofi | 12 | $362 |
| Boehringer Ingelheim | 15 | $334 |
| Electromed, Inc. | 24 | $250 |
| Insmed, Inc. | 9 | $167 |
| United Therapeutics Corporation | 7 | $164 |
| Verona Pharma, Inc. | 12 | $161 |
| Axsome Therapeutics, Inc. | 4 | $157 |
| Actelion Pharmaceuticals US, Inc. | 7 | $157 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $132 |
| Merck | 4 | $91 |
| Grifols USA, LLC | 4 | $88 |
| Sanofi-aventis U.S. LLC | 1 | $79 |
| Abiomed | 2 | $77 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Amgen | 3 | $60 |
| Viatris Specialty LLC | 3 | $58 |
| CSL Behring | 2 | $47 |
| Harmony Biosciences LLC | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
| Vifor Pharma, Inc. | 2 | $36 |
| Johnson & Johnson | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $27 |
| Baxter Healthcare | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Philips North America LLC | 1 | $23 |
| Pfizer | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
| AbbVie | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,736 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 265 | $192,964 |
| WakixPitolisant Hcl | 12 | $169,511 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 90 | $64,885 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 24 | $15,740 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $13,564 |
| SymbicortBudesonide/Formoterol Fumarate | 35 | $10,024 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $7,928 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 186 | $5,683 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 23 | $3,453 |
| Roflumilast | 16 | $3,146 |
| Arnuity ElliptaFluticasone Furoate | 12 | $2,085 |
| Wixela InhubFluticasone Propion/Salmeterol | 18 | $2,008 |
| Fluticasone Propionate | 40 | $718 |
| Montelukast Sodium | 49 | $527 |
| Levocetirizine Dihydrochloride | 23 | $489 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $752 | $216,541321 claims |
| Harmony Biosciences LLCWakix | $46 | $169,51112 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $955 | $74,910125 claims |
| Boehringer IngelheimStiolto Respimat | $334 | $15,74024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Anderson
- Owen MurryAnderson$8K
- Sherri CheekAnderson$8K
- Ashley BlackAnderson$8K
- Gayla PattersonAnderson$7K
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.